Cookies show us what works. Privacy
Cookies show us what works. Privacy
32 funds hold it · Insiders net buying
Net buying: insiders sold $0 and bought $162K on the open market in 90 days (SEC Form 4). Congress: both buying and selling, $3K to $45K in total in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Nov 4, 2026
Period ending
Sep 30, 2026
Earnings per share
$1.59 expected
Estimates as of Nov 11, 2026
EPS expected
$1.60 to $1.96
Revenue expected
22 analysts
Last 30 days
Split both ways
Estimate drift
Change in 30 days
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 30, 2026Reported Nov 4, 2026 | $1.99est. $1.59 | +25.35%beat | $842.0MSEC filing | +19.2%from $706.3M |
| Jun 30, 2026Reported Aug 5, 2026 | $1.66est. $1.45 | +14.28%beat | $801.7MSEC filing | +23.5%from $649.1M |
| Mar 31, 2026Reported May 6, 2026 | $1.42est. $1.19 | +19.26%beat | $761.7MSEC filing | +33.9%from $569.0M |
| Dec 31, 2025Reported Feb 18, 2026 | $1.55est. $1.46 | +5.97%beat | $783.8MAlpha Vantage | +31.2%from $597.5M |
| Sep 30, 2025Reported Nov 6, 2025 | $1.24est. $1.15 | +7.83%beat | $706.3MSEC filing | +29.9%from $543.9M |
| Jun 30, 2025Reported Aug 7, 2025 | $1.17est. $0.93 | +25.81%beat | $649.1MSEC filing | +32.9%from $488.5M |
| Mar 31, 2025Reported May 8, 2025 | $1.02est. $0.79 | +29.11%beat | $569.0MSEC filing | +28.8%from $441.7M |
| Dec 31, 2024Reported Feb 20, 2025 | $1.15est. $1.02 | +12.63%beat | $597.5MAlpha Vantage | +17.2%from $509.8M |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $783.8M | $761.7M | $801.7M | $842.0M |
| Cost of what it sold | $215.2M | $232.6M | $239.1M | $209.9M |
| Gross profit | $568.6M | $529.1M | $562.6M | $632.1M |
| What it spent | ||||
| Research and development | $90.9M | $89.7M | $88.1M | $91.6M |
| Sales and admin | $331.4M | $317.2M | $344.8M | $350.7M |
| Total operating expenses | $422.3M | $406.9M | $432.9M | $442.3M |
| What was left | ||||
| Operating profit | $146.3M | $122.1M | $129.7M | $189.8M |
| Interest on debt | $19.6M | $14.7M | $13.5M | $12.1M |
| Profit before tax | $140.2M | $113.0M | $118.7M | $177.2M |
| Tax | $38.5M | $21.9M | $23.7M | $36.1M |
| Net profit | $101.6M | $91.1M | $95.0M | $141.1M |
| EBITDA | $184.2M | $153.9M | $158.9M | $189.3M |
This stock's price action is mixed.
Trend
Mixed
55 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage leans bullish
Truist raises Insulet stock price target on Q4 guidance beat
NeutralNov 9Insulet launches “Give Yourself the Freedom to” campaign, encouraging people with diabetes to prioritize their well-being
BullishNov 9Insulet Corporation (PODD) PT Raised to $160 at Truist Securities
BullishNov 9American Express’s CEO Sold $99 Million of Stock the Day Before the Crash
Leans bearishNov 7Midday Pulse: S&P 500 top intraday losers
BearishNov 7Nasdaq achieves a 1% advance; indexes see big losses for the week
BearishNov 7What Is Behind The Move In DexCom Stock?
Leans bearishNov 7Helios Technologies stock hits 52-week low at 49.63 USD
Leans bearishNov 634 macro signals shaping PODD right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results